New study set to change how critically ill patients are treated

March 24, 2009

Brussels, 24 March 2009 --- The current practice of intensively lowering blood glucose in critically ill patients increases the risk of death by 10%. Results of the largest trial of intensive glucose lowering in critically ill patients published today in The New England Journal of Medicine indicate that international clinical guidelines need urgent review.

Intensive blood glucose lowering has been widely recommended and embraced to control hyperglycemia (high blood sugar) which is extremely common among acutely ill patients and linked with serious complications such as organ failure and death. These new findings reveal that current practice to intensively lower blood glucose increases the risk of death among patients in the intensive care unit (ICU).

"Intensively lowering blood glucose in critically ill patients is not beneficial and may be harmful. Based on our findings, we do not recommend pursuing a normal blood glucose level in critically ill patients. We found that intensively lowering blood glucose levels increased a patient's risk of dying by 10%," said Chief Investigator, Professor Simon Finfer from The George Institute for International Health, which is affiliated with the University of Sydney.

Researchers from The Australian and New Zealand Intensive Care Society Clinical Trials Group, The George Institute for International Health, The Canadian Critical Care Trials Group and Vancouver Coastal Health Research Institute set out to clarify the target range for blood glucose levels in critically ill patients. They followed 6104 ICU patients in Australia, New Zealand, Canada and the USA for up to 90 days to assess whether the treatment would improve patients' chance of survival.

"Previous, smaller research studies have produced conflicting results and overall suggested that intensive blood glucose control didn't affect death rates in critically ill adults. This new study gives us more powerful information, based on this larger study with stronger evidence, we can conclude that targeting very low levels of blood glucose is not safe," said North American Chief Investigator Dr Dean Chittock of Vancouver Coastal Health and University of British Columbia, Vancouver, Canada.

There are over six million admissions each year to ICU's in North America. The new evidence suggests that current guidelines must be reviewed.

"It's essential that international guidelines reflect this new evidence. Many professional organizations recommend very tight glucose control for ICU patients - they will now need to take this new evidence into consideration and adjust recommendations accordingly," added Dr Chittock.
The study, NICE-SUGAR (Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation) randomly assigned patients to one of two target ranges for blood glucose; an intensive control target (81-108mg/dL; 4.5-6.0 mmol/L) or a conventional control target (180mg/dL; 10.0 mmol/L or less). Control of blood glucose was achieved by the use of an intravenous infusion of insulin.

A unique feature of the NICE-SUGAR study was standardized complex blood glucose management, which was accessed by multiple centres as a computerized algorithm.

Research Australia

Related Blood Glucose Articles from Brightsurf:

Researchers identify unique glucose-sensing neurons that regulate blood sugar
At Baylor College of Medicine and other institutions, researchers have identified a group of unique glucose-sensing neurons in the brain and how they work together to prevent severe hypoglycemia in mice.

New study links severe sleep apnea to higher blood glucose levels in African-Americans
African-Americans with severe sleep apnea and other adverse sleep patterns are much more likely to have high blood glucose levels -- a risk factor for diabetes -- than those without these patterns, according to a new study funded in part by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

Small rises in blood glucose trigger big changes in insulin-producing cells
This study provides a wealth of new data showing how beta cells behave at slightly raised levels of blood glucose -- still within the pre-diabetes range.

High blood glucose levels may explain why some flu patients experience severe symptoms
Influenza A (a highly contagious virus that causes annual flu epidemics worldwide) may trigger an inflammatory 'cytokine storm' -- an excessive immune response that can lead to hospitalization or even death -- by increasing glucose metabolism, according to a new study.

Loss of gland in eyelids may be a biomarker for elevated blood glucose in diabetes
In patients with diabetes, loss of the gland that helps lubricate the eye may be a sign of elevated blood glucose levels, according to research accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting.

Medtronic MiniMed 670G insulin pump allows 'excellent' blood glucose control
Patients with type 1 diabetes who use Medtronic's MiniMedTM 670G insulin pump system are able to maintain blood glucose levels in the targeted range over 71% of the time, according to a study that analyzed some 6 million days of real-world data.

'Revita' improves blood glucose levels, liver metabolic health in type 2 diabetes
Patients with poorly controlled type 2 diabetes who underwent a novel, minimally invasive, endoscopic procedure called Revita® duodenal mucosal resurfacing (DMR) had significantly improved blood glucose (sugar) levels, liver insulin sensitivity, and other metabolic measures three months later, according to new data from the REVITA-2 study.

Artificial pancreas system better controls blood glucose levels than current technology
Study based at the Icahn School of Medicine at Mount Sinai and other centers finds new system has safety, efficacy benefits for people with type 1 diabetes

New study sheds light on how blood vessel damage from high glucose concentrations unfolds
A mechanism in the cells that line our blood vessels that helps them to process glucose becomes uncontrolled in diabetes, and could be linked to the formation of blood clots and inflammation according to researchers from the University of Warwick.

Blood pressure and glucose control may prevent common arrhythmia
Blood-pressure and glucose control may be effective in preventing heart block, a common form of arrhythmia, and the subsequent need for a pacemaker, according to a study by researchers at UC San Francisco.

Read More: Blood Glucose News and Blood Glucose Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to